- 11th Jan 2021
- 29th Mar 2021
- Study level
- Enrolment status
- Alumnus; Other
- Staff donation
- Fund source
- Perpetual Trust (UOM)
- Fund basis
In 2018, Professor Christopher Murray, Director of the Institute for Health Metrics and Evaluation (IHME) at the University of Washington and the University of Melbourne Laureate Professor Alan Lopez were jointly awarded the prestigious 2018 John Dirks Canada Gairdner Global Health Award for their pioneering work in establishing and developing the Global Burden of Disease (GBD) Study over three decades earlier. Subsequently, the GBD has greatly influenced debates about global health priorities and the development of health services and systems worldwide, and enabled the tracking of progress towards global and national health and development goals. Both have donated the shared proceeds of this award to their respective universities to establish the Murray-Lopez Award.
The primary aim of the Award is to support emerging global health researchers to carry out innovative research to improve the measurement and knowledge about burden of disease in populations. It is expected that both the University of Melbourne and the University of Washington will each make one award annually, commencing in 2021.
This year, the winner of the University of Melbourne Murray-Lopez Award will receive AUD$6,654.00 to support their research. Applications are encouraged that address any aspect of burden of disease measurement including analytical methods, disease, injury and risk factor models, data generation and assessment, prevalence and incidence of disease and injury, and valuation of health states.
Disclaimer: The benefit amount for this award is approximate. It will be confirmed at the time of awarding and determined by the committee according to the terms of the award.
Nominations must be submitted on behalf of the nominee. Self-nominations will not be reviewed. Nominees may be affiliated with any university or research organisation. The Murray-Lopez Award is open to individuals who meet the following criteria:
- An early‐career professional (defined as no more than five years post terminal degree and may include students pursuing a terminal degree).
- Demonstrable evidence that the nominee can carry out GBD research1 of the highest scientific quality, focused on either:
- Methods improvement; or
- Application of GBD methods in low- and middle-income countries (LMIC)2
- Preference will be given to candidates who are based in a LMIC.
1 “GBD-related research” defined as research or analysis that fits under the rubric of the Global Burden of Disease Study.
2 “LMIC” defined by the World Bank as: “For the current 2020 fiscal year, low-income economies are defined as those with a GNI per capita, calculated using the World Bank Atlas method, of $1,025 or less in 2018; lower middle-income economies are those with a GNI per capita between $1,026 and $3,995; upper middle-income economies are those with a GNI per capita between $3,996 and $12,375; high-income economies are those with a GNI per capita of $12,376 or more.” For a full list of countries: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
- Nominee’s personal information: title, name, degrees, position or role, organization, nationality, email, phone number, and physical address.
- Nomination letter providing context for the research (1,000-word limit). The nomination letter should:
- Describe the reason for the nomination (e.g. why this researcher is deserving of the Award).
- Describe the nominee’s accomplishments with regard to conducting Global Burden of Disease (GBD) research1 of the highest scientific quality, focused on either:
- Methods improvement; or
- Application of GBD methods in low and middle income countries (LMIC)2
- Describe their career to date (to prove eligibility for the Award)
- Supporting materials (2 maximum). Please attach additional items that support the nominee’s use of evidence to positively impact health: piece of published research or completed, unpublished manuscript (for example, a thesis or capstone).
- Curriculum vitae (CV).
- Nominator’s personal information: title, name, degrees, position or role, organization, email, phone number, and physical address.
Nominations must be submitted on behalf of the nominee. Self-nominations will not be reviewed. Nominations for 2021 should be received no later than 29 March 2021. As the evaluation of nominees depends on the information supplied, nominations should be accurate, detailed, and complete. We prefer nominations in English. Due to organizational capacity, we cannot guarantee that applications in languages other than English will be reviewed.
If you have any questions, please contact: firstname.lastname@example.org.
This Award is being jointly promoted by IHME at the University of Washington and the University of Melbourne. Only one nomination per nominee will be eligible.
Website/applications open: 11 January 2021. Applications close: 29 March 2021. Applicants will be notified by email of the outcome of their application.
For enquiries: Jane Inall, Senior Project Coordinator, Global Burden of Disease Group, Email: email@example.com
The selection process: Applications will be reviewed by a committee of burden of disease experts and two winners will be selected (one for the University of Washington-administered Award and one for the University of Melbourne-administered Award).
Population and Global Health